Asia-Pacific is expected to exhibit the most potential market with CAGR 9.7% for 2015-2019, fueled by increasing number of technology companies within the region, increasing investment in healthcare, entry of foreign pharmacy and hospital chains and improving economy.

Houston, TX -- (ReleaseWire) -- 09/04/2015 -- Written prescriptions were one of the major sources for confusion and medication errors in the past, and this gave rise to need for devising the system where pharmacists, nurses and physicians would be on the same page. The advent and rise of barcoding, RFID and software in healthcare area greatly enhanced the efficiency of all automation systems in healthcare facilities and drastically began reducing errors. Automated medication dispensing systems fill prescriptions and dispense them to the patient or caregiver. Large automated medication dispensing systems can handle over 700-800 prescriptions or more per day. However, comparing the size of most independent pharmacies and stores, the set-up may be installed in order to handle around 300-500 prescriptions each day. These machines are regulated stringently by the healthcare authorities since many devices handle crucial and potentially damaging drugs as well. Demand for automated medication dispensing will continue to grow solidly across regions at a CAGR of 6.2% from 2015 to 2019. The market for automated dispensing systems is fragmented although consolidation through mergers & acquisitions and strategic collaborations continue. Key players in this market segment are Omnicell & MTS, ScriptPro, CareFusion, Talyst, Parata Systems, Cerner, InterMetro Industries (Metro Automated Dispensing), JVM (Korea), Capsa Solutions, Willach Pharmacy Solutions, Mach 4 Pharma Systems, Remidi, Synergy Medical (Synergie Medicale BRG Inc), Tosho, CRETEM Co Ltd, ARxIUM and Noritsu Medical among others.

To read further, please click here: http://www.sa-brc.com/publish-global-pharmacy-automation-systems-market.php

Consolidation within the pharmacy automation market continues along with similar trends seen across logistics and intralogistics industry. With over nine notable mergers and acquisitions of key players such as Swisslog, CareFusion, AmerisourceBergen and Kirby Lester, the market is considered to be very profitable in coming years. CareFusion registered solid earnings from its dispensing Systems segment in 2014 and led the market. Omnicell, Becton Dickinson, Capsa Solutions, Aesynt have made the recent headlines with acquisitions across the board. Due to a healthy investment by governments in major markets, centralized pharmacy automation will continue to grow and demand more automation in coming years. Even with price tags of US$ 1.0 million, storage and retrieval devices continue to be installed since they guarantee quick ROI, significant reduction in labor costs and almost error free medication dispensing.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Asia-Pacific, Latin America and Middle-East are expected to be the most potential market with CAGR 7.8%, 7.8% and 9.0% respectively for 2015-2019, whereas Africa is expected to present a burst in growth (CAGR 11.2%) primarily due to investment in the region by major players.

Houston, TX -- (ReleaseWire) -- 08/14/2015 -- SA-BRC analysts monitored trends in the external beam radiation therapy devices market across 6 regions of North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa. Radiotherapy has been accepted as the standard procedure for oncology treatments. Growing cancer cases boost up the prevalence of this treatment procedure globally at a very fast pace. This report covers the market analysis for various external beam radiotherapy devices or EBRT devices such as Gamma Knife, Cyber Knife, TomoTherapy, LINACs and Proton Beam Therapy.

To read further, please click here:
http://www.sa-brc.com/publish-global-external-beam-radiation.php

The radiotherapy market has undergone dramatic and rapid technological evolutions since last few decades. New technologies have emerged to address the unmet needs of huge cancer populations worldwide. Starting with the basic X-ray emitting machines, radiotherapy has been turned into one of the most sophisticated therapeutic procedures. Initial radiotherapy devices were capable of only emitting radiations, with no presence of beam modulation facilities to control the hazardous effects of radiations. 3-D CRT was the first revolutionary breakthrough that ensured the conformal dose of radiation for protecting neighbouring healthy tissues. This technology helped in driving the radiotherapy market rapidly. The 3-D CRT technology was carried forward with the new invention in the radiotherapy technology, that is, conventional IMRT technology. It was designed depending on the basic idea of 3-D CRT, but with some new features that provides better clinical outcomes.

To read further, please click here:
http://www.sa-brc.com/publish-global-external-beam-radiation.php

IMRT provides precise control on dose escalation to modulate the intensity of radiation beam. With the growing popularity of IMRT, researchers started incorporating some new features to address the service gap of conventional IMRT technology. For most of large market players innovation is not a core competency. For unique technologies such companies are dependent on acquisition of small companies. Though big market players have the required capital for acquiring new technologies from emerging market players and researchers, they still have to compete with other competitors for particular new technologies.

The radiotherapy devices market is increasingly becoming price-competitive. This has led the existing several players to opt for collaboration for cutting-edge technologies from universities than rely on internal research. Large market players tend to quote high prices to acquire such technologies and limited number of unique and novel technologies in turn increases the bargaining power of innovators and research institutes. Furthermore, if the invention is unique and is already protected legally, then the supplier of such technology could argue for strong bargaining for the price of such technology. The ongoing demand for smaller, safer, faster and cheaper versions of existing radiotherapy products has resulted into reduction in the average life of such devices and thus the threat of substitution is high.

To read further, please click here:
http://www.sa-brc.com/publish-global-external-beam-radiation.php

Next generation IMRT and IGRT technology market has grown largely by providing better quality services, reimbursement policies and huge governmental support. Particle or proton beam or charged particle radiation therapy uses beams of protons or other charged particles to treat cancerous tumors. While standard radiation might cause damage to nearby healthy tissues, protons slow down their energy pulse, limiting the harmful impacts. Particle beam radiation therapy might target the radiation with a high degree of precision, but its potential advantages over other radiotherapy alternatives have not been proved in long-term outcome studies.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

North America continued to lead market for computed tomography systems with a share of 36.1% in 2014 that translated into revenues worth US$ 1,746.2 million.

Houston, TX -- (ReleaseWire) -- 08/13/2015 -- There are two major configurations of CT systems, stationary and portable. Stationary CT systems sweep an intense electron beam across a stationary anode target that surrounds the patient. The X-rays are produced by a semi-circular array of emitters and detected by another stationary circular array of sensors. There are over four generations of CT systems that are in use today of which several models are stationary. This report considers stationary CT systems as those which cannot be moved from one operating room to another. Stationary CT systems market took the higher share as compared to mobile/portable segment with 81.8% of the global CT systems market. There is a greater demand for more affordable water-cooled scanners as compared to air-cooled systems and the lowering prices of these systems is expected to generate significant demand in coming years. With recent FDA and EU directives to focus more on reducing dose exposure, the refurbished market will face a challenge as compared to new devices. On the contrary, in the U.S the directive on applying a 2.3% device tax to the new medical systems has brought the situation to a stalemate. Key players in the segment are GE Healthcare, Philips Healthcare, Siemens, Varian Medical Systems, Analogic Corporation. The market share also comprises of Asian powers such as Hitachi Medical and Toshiba.

To read further, please click here:
http://www.sa-brc.com/publish-global-computed-tomography.php

There are three configurations in terms of slices (images) namely, low-slice, mid-slice and high-slice systems. The mid-slice CT systems (32, 64, 128 slice) images with most common being 32 and 64 slice CT systems. Mid slice systems are very popular in developed regions of the world that can afford these expensive systems. North America, Japan, Western Europe and some other countries hold the largest market for mid-slice CT systems. Globally SA-BRC estimated the market share of mid-slice systems in terms of revenue to be 60.2% in 2014. The market is primarily being driven by the demand from large hospitals and expanding specialties in the area of cardiology. The 64 slice systems are best used for CT angiography and other applications such as stroke prevention that has been reduced by over 75% in the last five years. Diagnostic imaging with the help of 64 slice CT systems is the most effective method of identifying cardiovascular disorders.

To read further, please click here:
http://www.sa-brc.com/publish-global-computed-tomography.php

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Wearable Fitness Monitors & Trackers segment is estimated to grow the fastest between 2015 and 2019 capturing a market share of 59.6% in 2014.

Houston, TX -- (ReleaseWire) -- 08/12/2015 -- SA-BRC survey of over 3000 fitness band and smart watch users across the world showed that over 40% users did not care for display of details on the wearable device as long as they could keep tabs on their health parameters through mobile apps. This puts a question on whether smart watches will really take on the wearables market and shake down the share of popular fitness trackers such as the Flex, Shine, Up, Fuel among an increasing plethora of other options.

To read further, please click here:
http://www.sa-brc.com/publish-global-wearable-healthcare-electronic-devices.php

More than a decade ago, one of the most advanced wearable technologies was the heart rate tracker used by athletes around the world. However due to limitations of biosensors, these devices were prone to large percentages of errors and medical professionals had to rely on mobile and portable units in order to monitor the health of athletes. Wearable healthcare electronic devices have surpassed toughest challenges today and created water-proof sensors, reduced error margins by a significant percentage and introduced mobile apps to simplify and ease interpretation by users. The advent of telemetry and wireless technologies has enabled users to send health data wirelessly to their physicians which have reduced visiting charges, waiting period, round trips to clinics and a range of other disadvantages faced earlier. Wireless data transfer set into motion an important aspect of modern healthcare which is Big Data Analytics. The large numbers of wearable healthcare electronic devices are expected to create exabytes of health data on chronic diseases and disorders.

To read further, please click here:
http://www.sa-brc.com/publish-global-wearable-healthcare-electronic-devices.php

This market research encompasses a large variety of wearable healthcare electronic devices such as heart rate monitors, fitness moniters, activity monitors or fitness bands, wearable electrocardiograph (ECG), wearable electroencephalograph (EEG), blood pressure monitors, pain management devices, wearable pediatric and fetal monitoring devices, glucose monitoring devices and wearable respiratory devices. Considering this range of devices within the scope of research, SA-BRC analysis concluded that approximately 50 million wearable healthcare electronic devices were sold in 2014. The relaunch of devices such as Google glass will further supplement the growth of this market. Google faced a considerable backlash and criticism for Glass due to the potential encroachment into the privacy of people's lives. However, it found significant applications in healthcare. In 2015, at the Society of NeuroInterventional Surgery's annual meeting, doctors demonstrated how to use Google Glass in a medical setting. Putting the Glass in emergency medicine, military medicine and emergency rooms can give medical experts an excellent chance of saving more lives. Looking at a patient remotely prior to being brought in an emergency room will provide ample opportunity to set up the place on a case to case basis. Google Glass 2 called Google Enterprise, expected to be launched in 2016 will feature an upgraded processor, prism and external battery pack.

To read further, please click here:
http://www.sa-brc.com/publish-global-wearable-healthcare-electronic-devices.php

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The blood glucose monitoring devices segment controlled 64.5% of the market that translated into revenues of US$ 11, 458.3 million in 2014.

Houston, TX -- (ReleaseWire) -- 08/10/2015 -- Ambulatory blood pressure monitoring is the measuring of blood pressure levels of a patient at regular intervals over a period of 24 hours. Measurement of the blood pressure levels is carried out while the patient performs normal daily activities including sleep. Ambulatory blood pressure monitors increase the accuracy for the diagnosis of hypertension. Ambulatory monitoring may be useful for the diagnosis of white-coat hypertension and masked hypertension. These monitoring devices provide more accurate readings than the isolated clinical measurements. Ambulatory blood pressure measurement may disturb the sleep at night, or bruising under the inflating cuff may occur that will limit the adoption of ambulatory method for measuring the blood pressure levels. The current market for ambulatory blood pressure monitors is young and faces several strong challenges such as the advent of miniaturized wrist bound blood pressure monitors. Ambulatory devices are prone to be bulky and cannot be carried everywhere as opposed to wearable devices. . Due to the rising prevalence and incidence rate of hypertension, there is increased awareness about regular monitoring of blood pressure amongst people; also due to integration of telemedicine, patients themselves rely on self-monitoring of blood pressure at home. Such factors contribute to the growth of blood pressure monitoring devices market. Hence, blood pressure monitoring device manufacturing companies are developing innovative automatic blood pressure monitoring devices that provide accurate readings and will be easy-to-handle at home.

To read further, please click here: http://www.sa-brc.com/publish-global-blood-cardiac-monitors.php

Less than 5 years ago, most people were using injections to control diabetes across major parts of the world, however today they have more than 10 major brands of completely automated pumps and CGM devices that can keep their disease at bay. Most devices have easy-to-read full-color screens with extra features and are also rechargeable through standard USB cables. Cellphones integrated with blood and cardiac monitoring will become high in demand in future. We already see ECG applications, blood pressure monitors and even blood glucose monitors such as the One Touch Verio Sync. This commoditization of medical devices has led to greater awareness of diseases as well as technologies available to combat them.

To read further, please click here: http://www.sa-brc.com/publish-global-blood-cardiac-monitors.php

Considering the massive size of the target population and potential of developing technology, companies are going to be kept on their toes through integration and significant joint ventures expected in coming years between medical device companies and communication technology companies. A large unseen opportunity here is the service that lies in between such as massive data handling, physician and patient mediators and carrier service providers. Telecom companies may have faced losses through reduction of charges in calling and messaging, however the advent of these technologies may create a sizable opportunity for this sector in coming years.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

SA-BRC announces the release of its report on “Global Mass Spectrometry Technologies Market Assessment & Forecast: 2015-2019”. Tandem Mass Spectrometry segment accounted for 68.6% share of the total MS market and the Single Mass Analyzer MS systems accounted for 31.4%.

Houston, TX -- (ReleaseWire) -- 07/15/2015 -- Tandem mass spectrometry systems utilize two MS systems where the first round of MS causes precursors to fall apart by various techniques of degradation and the second round of mass spectrometry separates the fragmented components by weight. There are several tandem mass spectrometry combinations that are available based on the type of requirements raised by a buyer. The MALDI Triple-TOF, Q-TOF and triple quadrupole are the most utilized types of tandem mass spectrometers in demand today. Tandem MS has been applied to several emerging areas in healthcare and life-science such as metabolomics for studying vitamin biochemistry, environmental and food toxicology besides its primary use in proteomics. Some recent rat plasma studies have conducted research on various constituents such as brazilin and pinosylvin in pre-clinical pharmacokinetic studies and buflomedil in human plasma for bioequivalence studies. Q-TOF is expected to compete against FT-MS due to a competitive cost and quality in terms of resolution delivered by both systems.

To read further, please click here: http://www.sa-brc.com/publish-global-mass-spectrometry.php

Current mass spectrometry technologies have the ability to pinpoint the accurate molecules that can reduce chances of failure in clinical research. This will save cost and time in getting an effective drug for a critical illness to the market. Selecting a molecule for initiation into clinical testing and final marketing can take a period of over 10 years. The current MS technologies can save a tremendous amount of time as analysis on several potential molecules can be obtained in a short span. MS is not only used in drug discovery, but also applied in identification, detection analysis and testing. Recent advancements have created demand from sports authorities for urine sampling to reduce doping incidences at a higher rate. Previously, the amount of time taken to identify the drug used to be much longer which created a lapse and current technologies have greatly reduced the amount of time taken to obtain a result of a sample. There is a rising demand for mass spectrometry from metabolomics applied in pharmaceutical industry.

To read further, please click here: http://www.sa-brc.com/publish-global-mass-spectrometry.php

Due to the expiration of several blockbuster pharmaceutical molecules in the current decade and more expected to follow, mass spectrometry is expected to play a key role in reverse engineering and developing generic API combinations for local and regional markets alike. Increasing interest in personalized medicine and genetically specific vaccines and drugs, the technology has been instrumental in the burgeoning field of proteomics and genomics research.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

SA-BRC announces the release of its report on “Global Non-Vascular Stents Market Assessment & Forecast: 2015 - 2019”. The North American region (USA and Canada) accounted for 32.6% of the market, followed by Europe in 2014.

Houston, TX -- (ReleaseWire) -- 07/14/2015 -- A significant increase in cases of prostatic cancers and benign prostatic hyperplasia observed in Latin America has greatly enhanced the market demand with several players such as Allium Medical investing early on. Asian countries particularly Korea and Japan are strong markets with presence of companies such as Taewoong Medical, Stentech, Micro-Tech (Nanjing) Ltd and MI Tech. Since these devices are yet to receive marketing approvals, the cost of the devices is low and the sales are restricted to few international countries where market growth is moderate. Since several market players have originated from the Asian countries, the market opportunities in other regions of the world are abundant. Manufacturers have virtually untapped markets in Europe, Latin America, Middle-East and Africa.

To read further, please click here: http://www.sa-brc.com/publish-medical-non-vascular.php

The American Cancer Society's estimates for prostate cancer in the United States for 2014 are close to 233,000 new cases with 29,500 deaths. Aging population is another major driver that continues to push the growth of most healthcare markets and the same applies to the non-vascular stents market for North America. Unresectable colon cancer cases also continue to drive major GI non-vascular stents market. In the European Cancer Journal, an evaluation study for clinical safety and efficacy of percutaneous transhepatic hybrid biliary prostheses for palliative treatment in patients with common bile duct obstruction caused by advanced malignancies concluded that transhepatic hybrid biliary endoprostheses using both plastic and metallic stents can be useful as non-invasive palliative treatment to relieve jaundice in patients with malignant obstructive jaundice. According to WHO and Cancer Research UK, the Asian peninsula has one of the highest esophageal cancer rates in the world, which consists of unresectable pancreatic, duodenal adenocarcinoma and locally advanced esophageal cancer.

To read further, please click here: http://www.sa-brc.com/publish-medical-non-vascular.php

Biodegradable stents have been a boon for vascular as well as non-vascular applications since they do not require additional surgical procedures for removal. They are proven to be clinically safe as most biomaterials used in the manufacture are also used for making surgical sutures and with proven biocompatibility. Biodegradable stents are available for ureteral placement as well as for esophageal strictures. The market for biodegradable non-vascular stents is expected to grow significantly in coming years adding further value and momentum to this market.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

SA-BRC analysts monitored trends and analyzed five different imaging modalities that comprise the complete veterinary diagnostic imaging market. These include veterinary ultrasound, magnetic resonance imaging, computed tomography, X-ray and endoscopy.

Houston, TX -- (ReleaseWire) -- 07/13/2015 -- The report also presents the current market and forecast of veterinary diagnostic imaging equipment purchased by different end-users such as veterinary hospitals, veterinary clinics and emergency/point-of-care veterinary services. The geographical analysis of the veterinary diagnostic imaging devices is segregated into six regions of North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa.

To read further, please click here: http://www.sa-brc.com/publish-global-veterinary-diagnostic.php

Miniaturized ultrasound and X-ray devices are observed to be in great demand by veterinary clinics, hospitals and visiting veterinary practitioners across the world. Introduction of specialized emergency services for companion animals is expected to drive the market for diagnostic imaging in veterinary sector in coming years. In North America and Europe, there has been an increase of over 5,000 new pet emergency services in the past decade. All services require vehicles equipped with diagnostic imaging modalities such as ultrasound and X-ray. There are approximately 30,000 veterinary clinics and hospitals in North America. This represents a significant target market for all imaging modalities.

Veterinary imaging equipment and devices market faces greater challenge as compared to other veterinary healthcare products such as vaccines, pharmaceuticals and additives simply due to scale of economy. Vaccines and additives are used on a very large scale among livestock and farm animals as compared to companion animals although the latter segment is growing much faster. Due to highly unregulated pricing system for diagnostics and therapy, the veterinary services are directly affected by service to animals and customer service to patients. Surveys indicate that most people in a locality go to a veterinary hospital or clinic based on word-of-mouth marketing or suggestion by someone who has experienced the service.

To read further, please click here: http://www.sa-brc.com/publish-global-veterinary-diagnostic.php

Conventionally the concept of pets and companion animals among people in emerging countries were associated only with appropriate feeding and did not extend to intensive care of health, appetite and regular diagnostics. A burgeoning pet market in developing countries such as India, Venezuela, Brazil, Argentina, China and others has led to the globalization of the veterinary imaging technology manufacturers. The companies are now shifting focus on to a global level and creating distributorship across countries. Rising per capita income and greater awareness of animal welfare has increased the chances of veterinary professionals in these regions. There are significant challenges yet to be overcome such as lack of veterinary professionals in the region and low purchase power which is expected to continue downgrading the true potential of the opportunities. A large majority of players in the veterinary diagnostic imaging market are privately held and do not disclose their financial data.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

SA-BRC announces the release of its report on “Global Robotic Prosthetics, Exoskeletons and Assistive Rehabilitation Technologies Market Assessment & Forecast: 2015 - 2019". North America continued to lead market for robotics in healthcare with a share of 49.4% in 2014 that translated into revenues worth US$ 337.4 million.

Houston, TX -- (ReleaseWire) -- 07/10/2015 -- This study reports analysis on healthcare robotics trends across 6 regions of North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa. Increasing international conflicts have left a large number of wounded causing several thousand victims to end up as amputees every year. There are approximately 3-4 million people with seriously debilitating amputations across the world each year. In United States the total number of amputees living is approximately 2 million today.

To read further, please click here: http://www.sa-brc.com/publish-robotic-prosthetics.php

North America dominated the market in terms of market share in 2014 since it is the adopter market for medical robotic systems and therefore, touts of being the highest user of these systems with the greatest adoption of new technology. Moderate private reimbursement policies and the presence of sophisticated healthcare infrastructure helps manufacturers gain a perfect platform for new product launches. Since the end-users of Exoskeletons and Assistive Rehabilitation systems include hospitals and clinics the segment currently shows a greater adoption, however this growth is anticipated to be for a short duration and is expected to stabilize at a single digit growth rate after the market matures by the next decade.

Europe followed North America in terms of market share in 2014. On account of their high accuracy and efficacy it is estimated that assistive and prosthetic robots will hold very high market penetration rates in Western European countries. Rise in patient awareness levels coupled with high economic growth in Eastern European countries will serve the European market as future growth opportunities. Both market leaders in prosthetics Ottobock and Ossur are based in Europe and have a substantial revenues generating from the region. Moreover, several research projects for intelligent prosthetics and rehabilitative systems are being conducted across the region. The high level of research and development activity ensures that Europe will continue to maintain pace with the growth in this market.

To read further, please click here: http://www.sa-brc.com/publish-robotic-prosthetics.php

Overseas investment is increasing across all companies. A large number of companies are also investing overseas in emerging countries such as China, India and Brazil. In two years Hocoma opened subsidiaries at Slovenia and Singapore in 2012 and 2010 respectively. Big international companies are also capable of following acquisition strategies in order to gather technology while at the same time even sponsoring R&D programs in top technology universities. For e.g. Ossur is a partner involved in the development of the Smart Hand prosthetic which is touted to be one of the most impressive neural prosthesis yet.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

SA-BRC announces the release of its report on “Global Neurodiagnostic and Monitoring Devices Market Assessment & Forecast: 2015-2019”. The Electroencephalography devices (EEG) segment was the largest market by value in 2014 that represented 55.0% of the total market.

Houston, TX -- (ReleaseWire) -- 07/09/2015 -- Due to the advent of wearable medical devices, the greatest shifting trend is observed in the commercialization and commoditization of EEG devices. Manufacturers such as Emotiv and Neurosky are introducing disruptive devices that can be used and interpreted easily by a user which is increasing awareness of neurological disorders at an unprecedented level. This will bring about a large demand for EEG devices in the near future. SA-BRC sees strong potential in four product areas that are commoditization of EEG as a wearable device, magnetoencephalography and expanding applications, non-invasive intra-cranial pressure monitoring and transcranial Doppler. The electroencephalography market is highly fragmented with a large number of local and regional players. Compumedics and Covidien are observed to be the only companies operating in multiple segments within the neurophysiological monitoring devices market, thus exhibiting wider reach in this market. An EEG device is compact and can be made ambulatory or portable. There are several factors that decide the cost of the device. All devices map electrical activity, yet software applications determine the number of functions that can be utilized which decide the cost of the device. An EEG test cost varies greatly from US$ 100 to US$ 500 in United States, approximately GBP 10 to GBP 25 in United Kingdom and approximately US$ 30 in India. The cost of the EEG device ranges from US$ 3,500 to US$ 10,000 over the world. North America and Europe account for over 67.1% of the global market for EEG devices. The distribution of the market can be attributed to the low awareness and intensity of research activities in the field of neurology and neuromonitoring segment.

To read further, please click here: http://www.sa-brc.com/publish-neurodiagnostic-and-monitoring.php

The MEG is more accurate than an EEG due to reduced effect of skin and tissue interference in magnetic fields, a characteristic that is encouraging the growth of the market. That being said, the device is several times more expensive than an EEG system and hence has a severe drawback for growth of sales. Elekta and CTF MEG Technologies hold most of the market share of which Elekta has succeeded in controlling the maximum market share. Installation of MEG systems by Asian counterparts has gone mostly unnoticed; however SA-BRC analysis suggests installation of approximately 100 systems worldwide currently. Considering the growth in number of neurodiagnostic laboratories, positive estimates anticipate installation of over 30 MEG systems each year across the world.

To read further, please click here: http://www.sa-brc.com/publish-neurodiagnostic-and-monitoring.php

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm